Clinical Trials Browser

Afatinib × Tumor-Agnostic × 1 year × Clear all

NCT00716417 2025-08-05

Study to Determine the Maximum Tolerated Dose of BIBW 2992 (Afatinib) When Combined With Cisplatin/Paclitaxel or Cisplatin/5-FU in Patients With Advanced Solid Tumours

Phase 1 Completed

47 enrolled 18 charts

Neoplasms